News & Analysis

Intellia Therapeutics is soaring with a 47% increase this year. What's driving this biotech buzz and how could it tie into crypto markets? We explore the implications.

Whale Factor•2 days ago

The Dilemma Facing Asset Managers: To Block or Not to Block Investors

Asset managers are grappling with a tough decision: deny exit requests from private debt funds or compromise their principles. This is a important moment with implications for both traditional finance and the crypto world.

Whale Factor

Page 15 of 158

Latest News

Whale Factor•2 days ago

Intellia's 47% Surge: Is Cathie Wood's Biotech Bet a Crypto Signal?

Intellia Therapeutics is soaring with a 47% increase this year. What's driving this biotech buzz and how could it tie into crypto markets? We explore the implications.

Whale Factor•2 days ago

The Dilemma Facing Asset Managers: To Block or Not to Block Investors

Whale Factor

Page 15 of 158

•

2 days ago

Private Debt Funds Face Tough Choices Amid Investor Exit Requests

Private debt funds are facing a dilemma: block investor exits or honor them, risking their guiding principles. This shake-up could impact more than just traditional finance.

Whale Factor•2 days ago

Why Betting on Vertex Pharmaceuticals Could Boost Your Retirement Fund

Social Security cuts loom and retirement savings are key. Discover why Vertex Pharmaceuticals might be the stock to secure your financial future.

Whale Factor•2 days ago

Can This Biotech Stock Help You Retire a Millionaire? Here's What to Know

Saving for retirement is more critical than ever. One biotech stock holds promise for those with a long-term view. Discover why patience and the right picks matter.

Whale Factor•2 days ago

Dogecoin's Dizzying Journey: From 40,600% Gains to an 88% Drop - What Now?

Dogecoin soared to astronomical heights with a 40,600% increase over a decade, only to crash 88% off its peak. With volatility the norm, what's next for this meme cryptocurrency?

Whale Factor•2 days ago

Why Schwab's U.S. Dividend Equity ETF is the Smart Money Move in 2023

Discover why Schwab's U.S. Dividend Equity ETF is leading the pack. From its impressive 19% rise to potential market impacts, we've got the details.

Whale Factor•2 days ago

Why MicroStrategy's $48 Billion Bitcoin Treasury Matters More Than You Think

MicroStrategy's Bitcoin holdings are a massive $48 billion, but they're trading at a discount. What's driving this and what does it mean for the crypto market?

Whale Factor•2 days ago

Bitcoin Discount: Strategy's $48.4B Treasury Faces Unexpected Valuation Hiccup

Strategy's Bitcoin holdings, valued at $48.4 billion, are trading at a discount. What's driving this and who stands to gain or lose?

Whale Factor•2 days ago

Asia's Wealth Faces $1.6 Billion UN Funding Gap Challenge

As the UN grapples with a $1.6 billion funding shortfall, Asia's wealthy are called upon to fill the gap. But is fragmented philanthropy up to the task?

Whale Factor•2 days ago

Nvidia: Why the AI Giant Still Holds Surprises for Risk-Averse Investors

Nvidia's massive growth in AI accelerators hasn't matched its stock price momentum. Is this a golden opportunity for careful investors, or a red flag?

Whale Factor•2 days ago

The Hidden Power of Dividend Stocks: What Investors Can Learn

Dividend stocks have consistently outperformed non-payers for over 50 years, more than doubling their returns. Explore what this means for your crypto portfolio.

Whale Factor•2 days ago

Taiwan Semiconductor's Role in AI's Market Surge: A Two-Year Bet

TSMC is central to the AI infrastructure boom with its advanced chip manufacturing. But can it keep up with demand and competition? We dig into the numbers and risks.

Whale Factor•2 days ago

Childcare Costs Skyrocket: Families Face Impossible Choices as Expenses Soar

Childcare costs are spiraling out of control, leaving families and providers in a bind. With surging insurance and rent, many are wrestling with tough decisions. Dive into why this matters and what's at stake.

Whale Factor•2 days ago

Eli Lilly's Weight Loss Drugs Soar: But Is Chasing Yield a Better Bet?

Eli Lilly's weight loss drugs are driving growth, with a massive 175% revenue boost. But is there a better investment? We explore the numbers and the noise.

Whale Factor•2 days ago

Eileen Gu's Parade Triumph: A Symbol of Cultural Strength Amid Market Uncertainty

San Francisco's Chinese New Year parade celebrated hometown hero Eileen Gu, but what does this cultural event mean for the crypto world? In a market driven by sentiment and perception, Gu's dual heritage and success hold lessons for investors.

Whale Factor•2 days ago

San Francisco's Fire Horse Parade: Tradition Meets Modernity in a Cultural Celebration

San Francisco celebrated the Year of the Fire Horse with a parade led by Olympic champion Eileen Gu. What does this mean for cultural dynamics and potential economic impacts? Dive into the details.

Whale Factor•2 days ago

Bitcoin Miners Face Costly Reality: Break-Even Isn't Just About Power

Riot Platforms' case study reveals the complex layers of Bitcoin mining costs. While miners can often cover electricity costs, broader profitability remains elusive. Discover the full breakdown of mining economics and what it means for the industry.

Whale Factor•2 days ago

Alphabet's AI Ambitions Could Reshape the Tech World

Alphabet is diving deep into AI, taking on startups like OpenAI. But what does this mean for crypto and the tech world?

Whale Factor•2 days ago

Why 2026's Market Dip in 'Magnificent Seven' Stocks Could Spell Opportunity

The 'Magnificent Seven,' including Nvidia and Meta, are seeing declines in 2026. This drop might just be the opening investors are waiting for.